• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A novel platform for detection of CK+ and CK- CTCs.一种新型平台,用于检测 CK+ 和 CK-CTC。
Cancer Discov. 2011 Dec;1(7):580-6. doi: 10.1158/2159-8290.CD-11-0215. Epub 2011 Nov 3.
2
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.循环肿瘤细胞通过上皮-间质转化逃避基于 EpCAM 的检测。
BMC Cancer. 2012 May 16;12:178. doi: 10.1186/1471-2407-12-178.
3
Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.单独使用抗细胞角蛋白或与抗上皮细胞粘附分子抗体联合使用进行富集,可显著提高转移性乳腺癌患者循环肿瘤细胞检测的灵敏度。
Breast Cancer Res. 2008;10(4):R69. doi: 10.1186/bcr2131. Epub 2008 Aug 7.
4
EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.采用 ApoStream®技术,从接受初始系统治疗的乳腺癌患者中,通过上皮-间充质转化和癌症干细胞表型,实现 EpCAM 独立的循环肿瘤细胞分离。
PLoS One. 2020 Mar 26;15(3):e0229903. doi: 10.1371/journal.pone.0229903. eCollection 2020.
5
Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.结直肠癌循环肿瘤细胞中上皮和间充质标志物的表达及其临床意义
Oncotarget. 2017 Feb 7;8(6):9293-9302. doi: 10.18632/oncotarget.14065.
6
Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.卵巢癌中单个循环肿瘤细胞的基因表达谱分析——多标记基因panel的建立。 (注:这里“panel”可译为“组、面板等,结合语境可能是指一组相关基因,因未明确专业释义,保留英文更合适)
Mol Oncol. 2016 Aug;10(7):1030-42. doi: 10.1016/j.molonc.2016.04.002. Epub 2016 Apr 20.
7
Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.通过微滤捕获的循环肿瘤细胞的细胞计量学特征及其与CellSearch(®)循环肿瘤细胞检测的相关性。
Cytometry A. 2015 Feb;87(2):137-44. doi: 10.1002/cyto.a.22613. Epub 2014 Dec 16.
8
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.早期和转移性乳腺癌患者循环肿瘤细胞中表达的上皮间质转化标志物。
Breast Cancer Res. 2011 Jun 10;13(3):R59. doi: 10.1186/bcr2896.
9
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.转移性乳腺癌中循环肿瘤细胞的EpCAM非依赖性富集
PLoS One. 2015 Dec 22;10(12):e0144535. doi: 10.1371/journal.pone.0144535. eCollection 2015.
10
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.基于上皮-间充质转化标志物的循环肿瘤细胞表型检测在 HER2 阴性转移性乳腺癌一线化疗中的预后和治疗意义。
Cancer Commun (Lond). 2019 Jan 3;39(1):1. doi: 10.1186/s40880-018-0346-4.

引用本文的文献

1
Longitudinal CSF Tumor Cell Enumeration and Mutational Analysis as a Driver for Leptomeningeal Disease Management.纵向脑脊液肿瘤细胞计数与突变分析作为柔脑膜疾病管理的驱动因素
Cancers (Basel). 2025 Feb 27;17(5):825. doi: 10.3390/cancers17050825.
2
Label-free detection and simultaneous viability determination of CTCs by lens-free imaging cytometry.通过无透镜成像流式细胞术对循环肿瘤细胞进行无标记检测及同时测定其活力
Anal Bioanal Chem. 2025 Jan;417(1):95-107. doi: 10.1007/s00216-024-05624-y. Epub 2024 Oct 30.
3
Microfluidic Affinity Selection of B-Lineage Cells from Peripheral Blood for Minimal Residual Disease Monitoring in Pediatric B-Type Acute Lymphoblastic Leukemia Patients.微流控亲和选择外周血中的 B 系细胞,用于儿科 B 型急性淋巴细胞白血病患者的微小残留病监测。
Int J Mol Sci. 2024 Oct 2;25(19):10619. doi: 10.3390/ijms251910619.
4
The HER2 flip-HER2 amplification of tumor cells in the cerebrospinal fluid of breast cancer patients with leptomeningeal disease: implications for treating the LM tumor with anti-HER2 therapy.乳腺癌软脑膜转移患者脑脊液中肿瘤细胞的HER2反转-HER2扩增:对采用抗HER2疗法治疗软脑膜转移瘤的意义
Front Oncol. 2024 May 17;14:1402651. doi: 10.3389/fonc.2024.1402651. eCollection 2024.
5
Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide.追踪非小细胞肺癌中的柔脑膜疾病:一项使用CNSide的单机构经验。
Neurooncol Adv. 2023 Dec 9;6(1):vdad150. doi: 10.1093/noajnl/vdad150. eCollection 2024 Jan-Dec.
6
Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis.循环肿瘤细胞作为早期胰腺癌潜在的预后生物标志物:一项系统综述和荟萃分析。
World J Clin Oncol. 2023 Nov 24;14(11):504-517. doi: 10.5306/wjco.v14.i11.504.
7
Circulating tumor cells in gastric cancer: developments and clinical applications.胃癌循环肿瘤细胞:研究进展与临床应用。
Clin Exp Med. 2023 Dec;23(8):4385-4399. doi: 10.1007/s10238-023-01158-2. Epub 2023 Aug 7.
8
Diagnostic and Therapeutic Updates in Leptomeningeal Disease.脑膜疾病的诊断和治疗进展。
Curr Oncol Rep. 2023 Aug;25(8):937-950. doi: 10.1007/s11912-023-01432-2. Epub 2023 May 31.
9
Circulating tumor cells PD-L1 expression detection and correlation of therapeutic efficacy of immune checkpoint inhibition in advanced non-small-cell lung cancer.循环肿瘤细胞 PD-L1 表达检测与晚期非小细胞肺癌免疫检查点抑制治疗疗效的相关性。
Thorac Cancer. 2023 Feb;14(5):470-478. doi: 10.1111/1759-7714.14767. Epub 2023 Jan 11.
10
Liquid biopsy: current technology and clinical applications.液体活检:当前技术与临床应用。
J Hematol Oncol. 2022 Sep 12;15(1):131. doi: 10.1186/s13045-022-01351-y.

本文引用的文献

1
Efficient capture of circulating tumor cells with a novel immunocytochemical microfluidic device.利用新型免疫细胞化学微流控装置高效捕获循环肿瘤细胞。
Biomicrofluidics. 2011 Sep;5(3):34119-3411915. doi: 10.1063/1.3623748. Epub 2011 Aug 22.
2
Circulating tumor cell isolation and diagnostics: toward routine clinical use.循环肿瘤细胞的分离与诊断:迈向常规临床应用。
Cancer Res. 2011 Sep 15;71(18):5955-60. doi: 10.1158/0008-5472.CAN-11-1254. Epub 2011 Sep 6.
3
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.HER2 阳性循环肿瘤细胞对转移性乳腺癌患者的预后价值。
Int J Clin Oncol. 2012 Apr;17(2):96-104. doi: 10.1007/s10147-011-0260-0. Epub 2011 Jun 15.
4
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers.来自晚期前列腺癌和乳腺癌患者的循环肿瘤细胞同时表达上皮和间充质标志物。
Mol Cancer Res. 2011 Aug;9(8):997-1007. doi: 10.1158/1541-7786.MCR-10-0490. Epub 2011 Jun 10.
5
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.早期和转移性乳腺癌患者循环肿瘤细胞中表达的上皮间质转化标志物。
Breast Cancer Res. 2011 Jun 10;13(3):R59. doi: 10.1186/bcr2896.
6
Cancer theory faces doubts.癌症理论面临质疑。
Nature. 2011 Apr 21;472(7343):273. doi: 10.1038/472273a.
7
Molecular mechanisms of metastasis in breast cancer--clinical applications.乳腺癌转移的分子机制——临床应用。
Nat Rev Clin Oncol. 2010 Dec;7(12):693-701. doi: 10.1038/nrclinonc.2010.171. Epub 2010 Oct 19.
8
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.利用微涡旋产生的人字形芯片分离循环肿瘤细胞。
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18392-7. doi: 10.1073/pnas.1012539107. Epub 2010 Oct 7.
9
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.转移性乳腺癌患者循环肿瘤细胞 HER2 状态:一项前瞻性、多中心试验。
Breast Cancer Res Treat. 2010 Nov;124(2):403-12. doi: 10.1007/s10549-010-1163-x. Epub 2010 Sep 22.
10
Circulating tumor cells revisited.循环肿瘤细胞再探讨。
JAMA. 2010 Mar 17;303(11):1092-3. doi: 10.1001/jama.2010.292.

一种新型平台,用于检测 CK+ 和 CK-CTC。

A novel platform for detection of CK+ and CK- CTCs.

机构信息

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Cancer Discov. 2011 Dec;1(7):580-6. doi: 10.1158/2159-8290.CD-11-0215. Epub 2011 Nov 3.

DOI:10.1158/2159-8290.CD-11-0215
PMID:22180853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3237635/
Abstract

UNLABELLED

Metastasis is a complex, multistep process that begins with the epithelial-mesenchymal transition (EMT). Circulating tumor cells (CTC) are believed to have undergone EMT and thus lack or express low levels of epithelial markers commonly used for enrichment and/or detection of such cells. However, most current CTC detection methods target only EpCAM and/or cytokeratin (CK) to enrich epithelial CTCs, resulting in failure to recognize other, perhaps more important, CTC phenotypes that lack expression of these markers. Here, we describe a population of complex aneuploid CTCs that do not express CK or CD45 antigen in patients with breast, ovarian, or colorectal cancer. These cells were not observed in healthy subjects. We show that the primary epithelial tumors were characterized by similar complex aneuploidy, indicating conversion to an EMT phenotype in the captured cells. Collectively, our study provides a new method for highly efficient capture of previously unrecognized populations of CTCs.

SIGNIFICANCE

Current assays for CTC capture likely miss populations of cells that have undergone EMT. Capture and study of CTCs that have undergone EMT would allow a better understanding of the mechanisms driving metastasis.

摘要

未标记

转移是一个复杂的多步骤过程,始于上皮-间充质转化(EMT)。循环肿瘤细胞(CTC)被认为已经经历了 EMT,因此缺乏或表达低水平的上皮标志物,这些标志物通常用于此类细胞的富集和/或检测。然而,大多数当前的 CTC 检测方法仅针对 EpCAM 和/或细胞角蛋白(CK)来富集上皮 CTC,导致无法识别其他可能更重要的 CTC 表型,这些表型缺乏这些标志物的表达。在这里,我们描述了一群在患有乳腺癌、卵巢癌或结直肠癌的患者中不表达 CK 或 CD45 抗原的复杂非整倍体 CTC。这些细胞在健康受试者中未观察到。我们表明,主要上皮肿瘤的特征是类似的复杂非整倍性,表明在捕获的细胞中发生 EMT 表型转化。总的来说,我们的研究提供了一种高效捕获以前未被识别的 CTC 群体的新方法。

意义

目前用于 CTC 捕获的检测方法可能会错过已经经历 EMT 的细胞群体。对经历 EMT 的 CTC 的捕获和研究将有助于更好地理解驱动转移的机制。